Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FOLR1 positive
i
Other names:
FOLR1, Folate Receptor Alpha, Ovarian Tumor-Associated Antigen MOv18, Adult Folate-Binding Protein, Folate Receptor 1 (Adult), Folate Receptor, Adult, Folate Receptor 1, KB Cells FBP, FR-Alpha, FOLR, FBP, Folate Binding Protein, FRalpha
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2348
Related biomarkers:
Expression
‹
FOLR1 expression (21)
FOLR1 overexpression (6)
FOLR1 positive + TRPV6 positive (1)
FOLR1 expression (21)
FOLR1 overexpression (6)
FOLR1 positive + TRPV6 positive (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
FOLR1 positive
Ovarian Cancer
FOLR1 positive
Ovarian Cancer
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
A1
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
A1
FOLR1 positive
Peritoneal Cancer
FOLR1 positive
Peritoneal Cancer
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
FOLR1 positive
Fallopian Tube Cancer
FOLR1 positive
Fallopian Tube Cancer
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
FOLR1 positive
Ovarian Cancer
FOLR1 positive
Ovarian Cancer
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
mirvetuximab soravtansine-gynx
Sensitive: A1 - Approval
mirvetuximab soravtansine-gynx
Sensitive
:
A1
FOLR1 positive
Ovarian Cancer
FOLR1 positive
Ovarian Cancer
CBP-1008
Sensitive: C3 – Early Trials
CBP-1008
Sensitive
:
C3
CBP-1008
Sensitive: C3 – Early Trials
CBP-1008
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login